- A trend away from IPOs and the progress of six regional firms were discussed on Wednesday at the Mason Wells Biomedical Fund I annual meeting, held at the Wisconsin Athletic Club.
Limited partners, portfolio company executives, and guests of Mason Wells
met in Milwaukee to hear a speech from Mark Hessen, ......Full article >>>
chase emerging regional biotech companies, move the headquarters and displace workers. Recently, Madison-based Bone Care International announced that it is being acquired for $600 million by Massachusetts-based Genzyme Corp. Still uncertain is the future employment of approximately 170 employees.
Serial biotech entrepreneur and current CEO of Deltanoid Pharmaceuticals Hector DeLuca said,......Full article >>>
y revised their budget system around Mezzia software, replacing Excel and paper-intensive cash flow management systems.
: CEO Mark McLane said that ActiveIP
, the Madison firm's new software for brand information monitoring, provides the perfect structure for d......Full article >>>
cant royalty rate is in place. Deluca said several investment bankers have contacted the company to explore both IPO and acquisition strategies.
: A recent transplant from Missouri to Wisconsin, Zystor reported that tests of its therapeutics for lysosomal storage diseases have improved their targeting and have been successfully tested......Full article >>>
Source:wistechnology.com By Mike Klein and Les Chappell 06/15/05Related biology technology :1
. Germantown drug company hires pharma veteran James Davidson as COO2
. Georgia stem cell company likely to stay put3
. Surgical products company wins Governors Business Plan Contest4
. Madison stem cell company gets $1M from state5
. Software company enters health space with RFID solutions on hold6
. Delaware company will keep NameProtect here7
. IPO-bound NimbleGen traveling in fast company8
. Wisconsin tries to woo another stem cell company9
. RedPrairie acquires Denver software company10
. Users help software company morph in new directions11
. UW scientist, former WiCell director found stem cell company